Tenet Healthcare Corporation
Tenet Healthcare Corporation (THC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
thc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Tenet Healthcare Corporation (THC) measures how much investors pay for each dollar of the company's trailing earnings. THC's current PE ratio of 8.06x is calculated by dividing its stock price of $161.69 by its TTM earnings per share of $19.62. −21.5% discount vs 5Y avg 10.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 13 fiscal years · Front-end computedMinQ1 · 25%12.7x
MedianQ3 · 75%413.0x
Max
At 8.06x, THC's current P/E is lower than in 15% of its annual fiscal year readings over the past 13 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Tenet Healthcare CorporationYou THC | $13.9B | 8.06x | -54.0% | $19.62 |
 Acadia Healthcare Company, Inc. ACHC | $2.3B | N/A | — | -$12.16 |
 Addus HomeCare Corporation ADUS | $1.7B | 20.66x | +17.8% | $5.20 |
 AMN Healthcare Services, Inc. AMN | $1.2B | N/A | — | -$2.48 |
 Brookdale Senior Living Inc. BKD | $2.8B | N/A | — | -$1.12 |
 DaVita Inc. DVA | $12.4B | 13.10x | -25.3% | $8.67 |
 Encompass Health Corporation EHC | $10.1B | 18.84x | +7.5% | $5.63 |
Industry Average 3 peers with valid PE | — | 17.53x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 12.73x | $15.61 | +233.1% | |
2024-12-31 FY2024 | 3.82x | $33.02 | -69.6% | |
2023-12-31 FY2023 | 12.57x | $6.01 | -1.0% | |
2022-12-31 FY2022 | 12.69x | $3.84 | +32.9% | |
2021-12-31 FY2021 | 9.55x | $8.56 | -9.1% | |
2020-12-31 FY2020 | 10.51x | $3.80 | — | |
2019-12-31 FY2019 | — | $-2.08 | — | |
2018-12-31 FY2018 | 16.83x | $1.02 | — | |
2017-12-31 FY2017 | — | $-7.00 | — | |
2016-12-31 FY2016 | — | $-1.93 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Tenet Healthcare Corporation (THC) measures how much investors pay for each dollar of the company's trailing earnings. THC's current PE ratio of 8.06x is calculated by dividing its stock price of $161.69 by its TTM earnings per share of $19.62.
Frequently asked questions
THC pe ratio · 6 questionsTHC's current PE ratio is 8.06x as of 2026-06-08, based on a stock price of $161.69 and TTM EPS of $19.62. Data sourced from Financial Modeling Prep via THC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Tenet Healthcare Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08